J. Bibeau

The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review

C. Beauchemin, J. Lachaine, D. Parison, 2021, Advances in Therapy.

Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine

C. Beauchemin, J. Lachaine, P. Chokka, 2018, CNS Spectrums.

PCN191 Cost Associated with Implementation of CAR T-Cell Therapy for the Management of Hematologic Cancers in Canada.

J. Lachaine, G. Ball, M. Jain, 2021 .

Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine

C. Beauchemin, J. Lachaine, P. Chokka, 2019, CNS Spectrums.